Articles published by AstraZeneca![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
ULTOMIRIS® (ravulizumab-cwvz) Approved in the US for Adults with Generalized Myasthenia Gravis
April 28, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]() ![]() ![]()
AstraZeneca Announces New Partnership with The National Fish and Wildlife Foundation to Plant One Million Trees
March 24, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]() ![]()
Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis
January 24, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]()
IMFINZI® (durvalumab) Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer
January 18, 2022
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|